De-escalation from natalizumab in multiple sclerosis: recurrence of disease 
activity despite switching to glatiramer acetate

Havla, J.; Gerdes, L. A.; Meinl, I.; Krumbholz, M.; Faber, H.; Weber, F.; Pellkofer, H. L.; Hohlfeld, R.; Kümpfel, T.

Lokale TagsFreigabegeschichteDetailsÜbersicht

De-escalation from natalizumab in multiple sclerosis: recurrence of disease activity despite switching to glatiramer acetate

Havla, J., Gerdes, L. A., Meinl, I., Krumbholz, M., Faber, H., Weber, F., et al. (2011). De-escalation from natalizumab in multiple sclerosis: recurrence of disease activity despite switching to glatiramer acetate. Journal of Neurology, 258(9), 1665-1669.

Item is Freigegeben

einblenden: alle ausblenden: alle

Basisdaten

einblenden: ausblenden:

Datensatz-Permalink: https://hdl.handle.net/11858/00-001M-0000-000E-8DBA-9 Versions-Permalink: https://hdl.handle.net/11858/00-001M-0000-000E-8DBB-7

Genre: Zeitschriftenartikel

ausblenden:

Urheber:
Havla, J., Autor
Gerdes, L. A., Autor
Meinl, I., Autor
Krumbholz, M.¹, Autor
Faber, H.¹, Autor
Weber, F.¹, Autor
Pellkofer, H. L., Autor
Hohlfeld, R., Autor
Kümpfel, T.², Autor

Affiliations:
1AG Weber, Frank, Florian Holsboer (Direktor), Max Planck Institute of Psychiatry, Max Planck Society, ou_1607164
2Max Planck Institute of Psychiatry, Max Planck Society, ou_1607137